New aspects of natural-killer-cell surveillance and therapy of cancer.
Smyth
Mark J
MJ
Cancer Immunology Laboratory, Trescowthick Research Laboratories, Research Division, Peter MacCallum Cancer Institute, Locked Bag 1, A'Beckett Street, Melbourne 8006, Australia. m.smyth@pmci.unimelb.edu.au
Hayakawa
Yoshihiro
Y
Takeda
Kazuyoshi
K
Yagita
Hideo
H
D000818:Animals; D017951:Antigen Presentation; D015703:Antigens, CD / Q000502:physiology; D017209:Apoptosis; D051017:Apoptosis Regulatory Proteins; D016026:Bone Marrow Transplantation; D003602:Cytotoxicity, Immunologic; D053222:Fas Ligand Protein; D006801:Humans; D007157:Immunologic Surveillance; D007167:Immunotherapy / Q000379:methods; D016219:Immunotherapy, Adoptive; D007371:Interferon-gamma / Q000502:physiology; D007694:Killer Cells, Natural / Q000276:immunology* / Q000637:transplantation; D008562:Membrane Glycoproteins / Q000502:physiology; D051379:Mice; D018448:Models, Immunological; D009369:Neoplasms / Q000276:immunology* / Q000628:therapy; D011971:Receptors, Immunologic / Q000276:immunology; D015398:Signal Transduction; D053221:TNF-Related Apoptosis-Inducing Ligand; D014184:Transplantation, Homologous; D019139:Tumor Escape; D014409:Tumor Necrosis Factor-alpha / Q000502:physiology
D015703:Antigens, CD; D051017:Apoptosis Regulatory Proteins; C505661:FASLG protein, human; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D008562:Membrane Glycoproteins; D011971:Receptors, Immunologic; D053221:TNF-Related Apoptosis-Inducing Ligand; C505653:TNFSF10 protein, human; C505654:Tnfsf10 protein, mouse; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma